Sponsor or institution

Clinical trials and research at Shanghai Escugen Biotechnology Co., Ltd

• 2Clinical trials
• 1Country

All recruiting trials (2)

• ESG406 treatment in adults with advanced or metastatic solid tumors

  This Phase 1 study will test whether ESG406 is safe and shows early signs of benefit in adults with advanced or metastatic solid tumors who have no standard treatment options.

  Recruiting at 3 sites Phase 1 Shanghai Escugen Biotechnology Co., Ltd · Chongqing, Chongqing Municipality and 2 other locations · NCT06979674

• Evaluating ESG206 for treating primary immune thrombocytopenia

  This study is testing a new treatment called ESG206 to see if it can safely help people with primary immune thrombocytopenia improve their condition.

  Recruiting Phase 1/2 Shanghai Escugen Biotechnology Co., Ltd · Jinan, Shandong · NCT06853444

Quick answers

How many clinical trials run by Shanghai Escugen Biotechnology Co., Ltd are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →